The present invention relates to a novel crystalline form of (2R)-(3-amino-2- fluoropropyl)phosphinic acid, the present invention is also directed to the use of the crystalline form for the treatment of gast rointestinal disorders as well as to a pharmaceutical composition comprising the same and a process for the preparation of the crystalline form.
本发明涉及一种新的晶体形式的(2R)-(3-
氨基-2-
氟丙基)
膦酸,本发明还涉及使用该晶体形式治疗胃肠道疾病的方法,以及包含该晶体形式的制药组合物和制备该晶体形式的方法。